Sebastian Szmit/LinkedIn
May 19, 2026, 14:35
Sebastian Szmit: Our Editorial on Edoxaban for Treatment of Cancer-Associated DVT Is Now Live
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
”Our Editorial ‘Edoxaban for treatment of cancer-related isolated distal deep vein thrombosis: harnessing evidence, seeking equipoise’ has been published online in Journal of Thrombosis and Thrombolysis.”
Title: Edoxaban for treatment of cancer-related isolated distal deep veinthrombosis: harnessing evidence, seeking equipoise
Authors: Andrea Minghini, Sebastian Szmit, Pietro Ameri
Stay updated on all scientific advances with Hemostasis Today.
-
May 19, 2026, 14:30Join NBCA’s Next PEP Talk on Supporting Individuals Navigating Life After a Blood Clot Diagnosis
-
May 19, 2026, 14:29Ossama Mansour: The Beginning of a National Transformation from Libya’s First Stroke Conference
-
May 19, 2026, 14:21Julie Makani: Blood Transfusion in Sickle Cell Disease in Africa
-
May 19, 2026, 14:00Noelia Grande Gutiérrez: Scale-Dependent Mechanisms of Near-Wall Platelet Enrichment in Arterial Flows
-
May 19, 2026, 13:51Antiphospholipid Syndrome: A Thrombo-Inflammatory Autoimmune Disorder Associated with Thrombosis and Pregnancy Morbidity
-
May 19, 2026, 13:08Robin Young: Complex PCI and the Challenge of Balancing Ischemic and Bleeding Risk
-
May 19, 2026, 11:50Nigusu Tesema: What Is Deep Vein Thrombosis and Why Does It Matter After Surgery?
-
May 19, 2026, 11:50Jason Bobay: Highlights Data-Driven DVT Prevention in International Compression Conference
-
May 19, 2026, 11:50Karl Egan: PEDNET Registry Insights Into Inhibitor Development in Severe Haemophilia A